Skip to main content
Livermore
Livermore
ZHEN

Jupiter Neurosciences, Inc.

JUNS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001679628

No open-market purchases or sales by Jupiter Neurosciences, Inc. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $826.9K in total; no superinvestor holds it.

Holders of 5% or more of JUNS

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Jupiter Neurosciences, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of JUNS
HolderLatest formStakeChangeFirst filedLatest filingFiling
PharmAla Biotech Holdings Inc.13G17.30%132.9K sharesNewSep 22, 20261 filingSep 22, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

8 Schedule 13D and 13G filings on Jupiter Neurosciences, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on JUNS
Filed (ET)FilerFormStakeChangeEvent dateFiling
Sep 22, 202611:59 AM ETPharmAla Biotech Holdings Inc.13G17.30%132.9K sharesNewAug 20, 2026SEC
Aug 28, 20265:01 PM ETOrca Capital AG13G/A3.30%39.9K shares−5.10 ppfrom 8.40%Below 5%Aug 21, 2026SEC
Aug 28, 20264:59 PM ETOrca Capital AG13G8.40%102.6K sharesNewAug 21, 2026SEC
Nov 15, 2024Hayward Marshall A.13DOld format–New–SEC
Nov 15, 2024Rosen Christer13DOld format–New–SEC
Nov 15, 2024Brothers Shaun Paul13DOld format–New–SEC
Nov 15, 2024Wahlestedt Claes Robert13DOld format–New–SEC
Nov 15, 2024Rosen Alexander Gustaf Erik13DOld format–New–SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Jupiter Neurosciences, Inc. shares.

No Form 144 notices for Jupiter Neurosciences, Inc. are on file.